Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Robertson

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Law & Medicine|August 19, 2011
The money blind: how to stop industry bias in biomedical science, without violating the First AmendmentChristopher T Robertson
The American Journal of Bioethics : AJOB|December 10, 2009
Why intuitions and metaphysics are the wrong approach for health law: a commentary on Delaney and HershenovChristopher T Robertson
American Journal of Law & Medicine|November 1, 2017
Vaccines and Airline Travel: A Federal Role to Protect the Public HealthChristopher T Robertson
The New England Journal of Medicine|August 20, 2015
New DTCA Guidance--Enough to Empower Consumers?Christopher T Robertson
Yale Journal of Health Policy, Law, and Ethics|December 10, 2014
Scaling cost-sharing to wages: how employers can reduce health spending and provide greater economic securityChristopher T Robertson
American Journal of Law & Medicine|July 14, 2020
Telehealth for an Aging Population: How Can Law Influence Adoption Among Providers, Payors, and Patients?Tara Sklar, Christopher T Robertson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 30, 2014
Heterogeneity in IRB policies with regard to disclosures about payment for participation in recruitment materialsMegan S Wright, Christopher T Robertson
Biopreservation and Biobanking|March 31, 2016
Federal Government's Proposed Expansion of Regulation of Biospecimen Research Should Be ReconsideredChristopher T Robertson, Jonathan D Loe
JAMA Internal Medicine|January 23, 2018
The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path ForwardAlison Bateman-House, Christopher T Robertson
Science (New York, N.Y.)|December 2, 2021
Challenges in confirming drug effectiveness after early approvalHolly Fernandez Lynch, Christopher T Robertson
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Law & Medicine|August 19, 2011
The money blind: how to stop industry bias in biomedical science, without violating the First AmendmentChristopher T Robertson
The American Journal of Bioethics : AJOB|December 10, 2009
Why intuitions and metaphysics are the wrong approach for health law: a commentary on Delaney and HershenovChristopher T Robertson
American Journal of Law & Medicine|November 1, 2017
Vaccines and Airline Travel: A Federal Role to Protect the Public HealthChristopher T Robertson
The New England Journal of Medicine|August 20, 2015
New DTCA Guidance--Enough to Empower Consumers?Christopher T Robertson
Yale Journal of Health Policy, Law, and Ethics|December 10, 2014
Scaling cost-sharing to wages: how employers can reduce health spending and provide greater economic securityChristopher T Robertson
American Journal of Law & Medicine|July 14, 2020
Telehealth for an Aging Population: How Can Law Influence Adoption Among Providers, Payors, and Patients?Tara Sklar, Christopher T Robertson
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 30, 2014
Heterogeneity in IRB policies with regard to disclosures about payment for participation in recruitment materialsMegan S Wright, Christopher T Robertson
Biopreservation and Biobanking|March 31, 2016
Federal Government's Proposed Expansion of Regulation of Biospecimen Research Should Be ReconsideredChristopher T Robertson, Jonathan D Loe
JAMA Internal Medicine|January 23, 2018
The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path ForwardAlison Bateman-House, Christopher T Robertson
Science (New York, N.Y.)|December 2, 2021
Challenges in confirming drug effectiveness after early approvalHolly Fernandez Lynch, Christopher T Robertson
Pageof 4